¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ(2ÀÏÂ÷) : 2023-04-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ(2ÀÏÂ÷) : 2023-04-22
±³À°ÀÏÀÚ : 2023-04-22
±³À°Àå¼Ò : ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ

±³À°ÁÖÁ¦ : 2023 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ(2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
´ã´çÀÚ : Á¶À±ÇÏ
¿¬¶ôó : 02-3275-5258  

À̸ÞÀÏ : herz8@circulation.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 120,000¿ø  

ºñ°í »çÀüµî·Ï: ±³¼ö ¹× °³¿øÀÇ-100,000, ÀüÀÓÀÇ/Àü°øÀÇ/±âŸ-70,000ÇöÀåµî·Ï: ±³¼ö ¹× °³¿øÀÇ-120,000, ÀüÀÓÀÇ/Àü°øÀÇ/±âŸ-90,000


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04-22 Convention Hall 3 09:00~09:20 How To Properly Assess for Venous Disease? ±èÇöÁø(ÇѾçÀÇ´ë)

±³À°½Ã°£ 04-22 Convention Hall 3 09:20~09:40 Venous Disease Treatment: Conservative Treatments ±è´ë¿µ(ÀÎÇÏÀÇ´ë)

±³À°½Ã°£ 04-22 Convention Hall 3 09:40~10:00 Interventional Therapy for Acute Pulmonary Embolism Juyong Lee(University of Connecticut School of Medicine USA)

±³À°½Ã°£ 04-22 Convention Hall 3 10:00~10:20 Surgical Management of Chronic Venous Insufficiency Patrick Muck(TriHealth Heart Institute Cincinnati USA)

Åä·Ð 04-22 Convention Hall 3 10:20~10:30 Discussion ()

ÈÞ½Ä 04-22 10:30~10:40 Break ()

±³À°½Ã°£ 04-22 Convention Hall 2 10:40~11:00 Inflammatory Myocardial Disease: Overview ±èÁöÈÆ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04-22 Convention Hall 2 11:00~11:20 Tissue Characterization by CMR: Can CMR Maintain the Current Position in the Future? ±è¼º¸ñ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04-22 Convention Hall 2 11:20~11:40 Myocardial Tissue and Metabolism Characterization by PET: PET can do What Others Cannot Á¶»ó°Ç(Àü³²ÀÇ´ë)

±³À°½Ã°£ 04-22 Convention Hall 2 11:40~12:00 Echocardiography with the Potential of Tissue Characterization: Echocardiography hasn¡¯t Given up yet Either À±¿¬ÀÌ(¼­¿ïÀÇ´ë)

Åä·Ð 04-22 Convention Hall 2 12:00~12:10 Discussion ()

ÈÞ½Ä 04-22 12:10~12:15 Break ()

±³À°½Ã°£ 04-22 Rm.210 12:15~12:55 Cutting Edge Care of Pitavastatin with Ezetimibe Combination Therapy ÀÌÁ¾¿µ(¼º±Õ°üÀÇ´ë)

ÈÞ½Ä 04-22 12:55~13:10 Break ()

±³À°½Ã°£ 04-22 Rm.214 13:10~13:25 Normal Cardiopulmonary Response to Exercise Àº¿µ¹Î(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04-22 Rm.214 13:25~13:40 Exercise Stress Echocardiography ±è¼ºÇý(Â÷ÀÇ´ë)

±³À°½Ã°£ 04-22 Rm.214 13:40~13:55 How to Perfom Cardiopulmonary Exercise Testing ³ªÀçÀ±(ÇѾçÀÇ´ë)

±³À°½Ã°£ 04-22 Rm.214 13:55~14:10 Special Consideration for Children & Adults with CHD during CPET ¼Û¹Ì°æ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-22 Rm.214 14:10~14:25 Interpretation of CPET Â÷½½±â(¿ï»êÀÇ´ë)

Åä·Ð 04-22 Rm.214 14:25~14:40 Discussion ()

ÈÞ½Ä 04-22 14:40~14:50 Break ()

±³À°½Ã°£ 04-22 Rm.210 14:50~15:10 Pro: Fibrate Still Has a Role in CV Risk Reduction ±è³²ÈÆ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04-22 Rm.210 15:10~15:30 Cons: Reducing TG Does Not Lower CV Risk ¿À±Ôö(°¡Å縯ÀÇ´ë)

Åä·Ð 04-22 Rm.210 15:30~16:10 Discussion ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ(2ÀÏÂ÷) : 2023-04-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¿ëÀνÃÀÇ»çȸ Ãá°è ¿¬¼ö°­Á : 2023-04-22
´ÙÀ½±Û 2023³â ´ëÇÑÀçÈ°ÀÇÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-04-22
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20698 ¼­¿ï 2024³â ´ëÇѳëÀκ´ÇÐȸ Á¦73Â÷ Çмú´ëȸ(Ãá°è)(2ÀÏÂ÷) : 2024-05-26 0 0 18:02:46
20697 ¼­¿ï (¿Â¶óÀÎ) 2024³â ±âº» ¼Ò¾Æ ÀÀ±Þ óġ ±³À°°úÁ¤ 1Â÷(BPECC) : 2024-05-26 0 0 18:01:30
20696 Ãæ³² Á¦ 28ȸ ¼øõÇâ ºñ´¢ÀÇÇаú ½ÉÆ÷Áö¿ò(2ÀÏÂ÷) : 2024-05-26 0 0 18:00:19
20695 Ãæ³² Á¦16Â÷ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­ ±³À° (»ó¹Ý±â_1ÀÏÂ÷) : 2024-05-26 0 0 17:59:06
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 93 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 52 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 61 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 67 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 56 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 56 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 30 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 25 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 50 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 26 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 28 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷